Oncology News

A multitarget stool DNA methylation assay accurately detected and identified the tissue of origin for multiple gastrointestinal cancers, according to study results presented at ASCO Breakthrough.

The FDA granted 510(k) clearance to Magentiq Eye’s artificial intelligence-aided software for real-time detection of gastrointestinal lesions during colonoscopy, according to a company press release.

The ACP recently issued guidance that recommends colorectal cancer screening in asymptomatic, average-risk adults starting at age 50 years, going against some other organizations that recommend screening at an earlier age.

Veterans who declined participation in a colorectal cancer screening trial more often preferred noninvasive testing over colonoscopy, a preference that increased over time and was especially evident among those in the western United States.

Liver transplant conferred a 10-year OS rate of more than 80% in selected patients with colorectal cancer and nonresectable liver metastases, study results showed.

A familial risk score comprised of age, obesity, type 2 diabetes and family history of nonalcoholic fatty liver disease accurately identified advanced fibrosis among first-degree relatives, according to researchers.

Proteins and genetic material secreted by fatty liver cells stimulate the spread of colorectal cancer to the liver, study results published in Cell Metabolism showed.

Intra-arterial administration of gemcitabine conferred a median PFS benefit of 8 months when compared with standard of care for patients with locally advanced pancreatic cancer, according to results of the phase 3 TiGeR-PaC study.

Computer-aided detection in colonoscopy had a “positive effect” on adenoma detection rate, mean number of adenomas per colonoscopy and polyp detection rate and should be considered when performing routine colonoscopy, researchers reported.

One-fifth of patients who underwent gallbladder cancer surgery at top-performing centers experienced related complications within 90 days, according to results of a retrospective study published in Annals of Surgical Oncology.